- Predictors of the risk of fibrosis at 10 years after breast conserving therapy for early breast cancer: a study based on the EORTC Trial 22881-10882 'boost versus no boost'Sandra Collette
Statistics Department, EORTC Headquarters, Brussels, Belgium
Eur J Cancer 44:2587-99. 2008..01) if WBI was given with >6 MV photons. The c-index was around 0.62. Nomograms with these factors are proposed to forecast the long-term risk of moderate or severe fibrosis...
- Quality assurance of radiotherapy in the ongoing EORTC 22042-26042 trial for atypical and malignant meningioma: results from the dummy runs and prospective individual case ReviewsMehtap Coskun
Department of Radiation Oncology, Ankara Oncology Hospital, Ankara, Turkey
Radiat Oncol 8:23. 2013..The results of the Dummy Run (DR) and prospective Individual Case Review (ICR) were analyzed in this Quality Assurance (QA) study...